Bio-Rad Laboratories (BIO) Net Income Growth (5y) (2014 - 2026)
Bio-Rad Laboratories (BIO) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Bio-Rad Laboratories | 8.57 Bn | 7.01 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.49% |
| Dec 31, 2025 | -3.20% |
| Sep 30, 2025 | -17.71% |
| Jun 30, 2025 | -19.94% |
| Mar 31, 2025 | -37.77% |
| Dec 31, 2024 | -26.92% |
| Sep 30, 2024 | 35.24% |
| Jun 30, 2024 | -41.22% |
| Mar 31, 2024 | -15.00% |
| Dec 31, 2023 | 19.35% |
| Sep 30, 2023 | -16.97% |
| Jun 30, 2023 | -44.66% |
| Mar 31, 2023 | -36.29% |
| Dec 31, 2022 | 58.52% |
| Sep 30, 2022 | -56.45% |
| Jun 30, 2022 | -184.30% |
| Mar 31, 2022 | -207.13% |
| Dec 31, 2021 | -142.44% |
| Sep 30, 2021 | 196.64% |
| Jun 30, 2021 | 123.03% |